Valuation (43%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -190.06 | 181.96 |
PEG Ratio (TTM) | -3.57 | -3.01 |
P/S Ratio (TTM) | 3.27 | 8.10 |
P/B Ratio (TTM) | 1.49 | 2.17 |
P/FCF Ratio (TTM) | 12.48 | -80.28 |
Price to 5YR AVG Earnings Ratio | -42.04 | 24.29 |
Price to 5YR AVG FCF Ratio | 15.53 | -263.99 |
Profitability (10%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.17% | 0.74% |
ROE (TTM) | -0.76% | 1.84% |
Net Profit Margin (TTM) | -1.72% | 6.28% |
ROIC 5YR AVG | 3.71% | 2.55% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -27.86% | -56.51% | -23.60% |
Revenue | -5.30% | 1.49% | 3.07% |
Net Income | -29.77% | -57.45% | -23.06% |
Cash Flow | 7.60% | 1.43% | 0.28% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.40 | 7.56 |
Quick Ratio (TTM) | 3.40 | 7.56 |
D/E Ratio (TTM) | 2.64 | 1.07 |
Interest Coverage (TTM) | 0.54 | 1.97 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 0.36 | 1.26 |
LTL to 5YR AVG FCF | 25.65 | -82.99 |
Shares Outstanding Growth 5YR AVG | -0.02% | 5.65% |